0000920465-20-000166.txt : 20201214
0000920465-20-000166.hdr.sgml : 20201214
20201214162453
ACCESSION NUMBER: 0000920465-20-000166
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201210
FILED AS OF DATE: 20201214
DATE AS OF CHANGE: 20201214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hearne Michael S
CENTRAL INDEX KEY: 0001759910
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 201386452
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE, SUITE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_160798107874420.xml
FORM 4
X0306
4
2020-12-10
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001759910
Hearne Michael S
C/O LA JOLLA PHARMACEUTICAL COMPANY
4747 EXECUTIVE DRIVE, SUITE 240
SAN DIEGO
CA
92121
0
1
0
0
Chief Financial Officer
Employee Stock Option (Right to Buy)
4.53
2020-12-10
4
A
0
52191
0
A
2030-12-10
Common Stock
52191.0
52191
D
The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
/s/ Michael Hearne
2020-12-14